All stock lists
Roma Green Finance Limited (NASDAQ:ROMA)
HK · Delayed Price · Currency is USD
Industrials · Consulting Services
7.00+2.31 (+49.25%)
Market cap
$374M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 9, 2024
Website
Insider Score
––Not scored
ROMA Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From ROMA’s reported statements · Q1 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $21.7M
- Net income
- -$54.6M
- Net margin
- -251.5%
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $6.9M
- Debt / equity
- 0.00
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $63.1M
- Current liabilities
- $2.8M
- Current ratio
- 22.19
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$32.1M
- Free cash flow
- -$32.1M
- FCF margin
- -147.9%
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 59.6M
- Share growth (1y)
- 551.0%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ROMA Income Statement
| Fiscal Period | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Mar 31, 2026 | Sep 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 |
| Revenue | 5.80 M | 3.71 M | 9.03 M | 3.17 M | 4.83 M | 5.08 M |
| Revenue Growth (YoY) | 20.10 % | -26.84 % | 21.18 % | -48.89 % | -39.73 % | -18.85 % |
| Cost of Revenue | 4.50 M | 3.46 M | 3.92 M | 3.77 M | 3.24 M | 3.55 M |
| Gross Profit | 1.29 M | 250.08 K | 5.11 M | -599.02 K | 1.58 M | 1.52 M |
| SG&A Expense | 12.59 M | 18.85 M | 16.38 M | 16.67 M | 5.94 M | 3.26 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.59 M | 18.85 M | 16.38 M | 16.67 M | 5.84 M | 3.26 M |
| Operating Income | -11.29 M | -18.60 M | -11.27 M | -17.27 M | -4.35 M | -1.74 M |
| Pretax Income | -9.82 M | -17.48 M | -10.52 M | -17.25 M | -4.08 M | -1.76 M |
| Tax Provision | 0.00 | 0.00 | 101.95 K | 103.12 K | 0.00 | -38.58 |
| Net Income | -9.82 M | -17.00 M | -10.42 M | -17.35 M | -4.08 M | -1.76 M |
| EPS (Basic) | -0.16 | -0.40 | -0.66 | -1.48 | -0.44 | -0.17 |
| EPS (Diluted) | -0.16 | -0.40 | -0.68 | -1.48 | -0.44 | -0.17 |
| Shares Outstanding | 59.56 M | 43.85 M | 15.45 M | 11.70 M | 9.15 M | 10.43 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.